Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-hCG immunization: introduction

G P Talwar

    Contraception
    |July 1, 1978
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Survivin targeting triple-fusion vaccine <sub>DC</sub>Survivin-LTB inhibits tumor growth in mouse model of triple-negative breast cancer.

    Medical oncology (Northwood, London, England)·2025
    Same author

    Expression, purification and characterization of a novel triple fusion protein developed for the immunotherapy of survivin positive cancers.

    Protein expression and purification·2024
    Same author

    Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers.

    Journal of drug targeting·2024
    Same author

    Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model.

    World journal of clinical oncology·2019
    Same author

    Immunotherapy approach with recombinant survivin adjuvanted with alum and MIP suppresses tumor growth in murine model of breast cancer.

    Preparative biochemistry & biotechnology·2018
    Same author

    Development of a novel recombinant LHRH fusion protein for therapy of androgen and estrogen dependent cancers.

    Protein expression and purification·2017
    Same journal

    Quantification of residual levonorgestrel following extended use of the levonorgestrel 52 mg intrauterine device beyond 8 years.

    Contraception·2026
    Same journal

    Mifepristone Provision Following Policy Shifts in 2022 & 2023.

    Contraception·2026
    Same journal

    Bleeding Experience with Medication Abortion Prior to Embryonic Cardiac Activity.

    Contraception·2026
    Same journal

    Importance of abortion training to residency program applicants: A national survey of OBGYN residents.

    Contraception·2026
    Same journal

    Racial and Demographic Trends in Abortion Method Selection in Minnesota Among in-State Patients at or under 11 Weeks Gestational Duration, 2021-2024.

    Contraception·2026
    Same journal

    Cervical preparation and induction of fetal demise practices for dilation and evacuation abortion between 24- and 27- weeks' gestation.

    Contraception·2026
    See all related articles